242 related articles for article (PubMed ID: 22829315)
1. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
Ma W; Wong CC; Tung EK; Wong CM; Ng IO
Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
[TBL] [Abstract][Full Text] [Related]
2. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.
Wong CC; Wong CM; Tung EK; Man K; Ng IO
Hepatology; 2009 May; 49(5):1583-94. PubMed ID: 19205033
[TBL] [Abstract][Full Text] [Related]
3. Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.
Grise F; Sena S; Bidaud-Meynard A; Baud J; Hiriart JB; Makki K; Dugot-Senant N; Staedel C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J; Moreau V
Hepatology; 2012 Jun; 55(6):1766-75. PubMed ID: 22234932
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ROCK by RhoE.
Riento K; Ridley AJ
Methods Enzymol; 2006; 406():533-41. PubMed ID: 16472685
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of RhoE is associated with progression and poor prognosis in hepatocellular carcinoma.
Luo H; Dong Z; Zou J; Zeng Q; Wu D; Liu L
J Surg Oncol; 2012 Jun; 105(7):699-704. PubMed ID: 22213123
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
[TBL] [Abstract][Full Text] [Related]
7. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [Abstract][Full Text] [Related]
8. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-I signalling.
Talens-Visconti R; Peris B; Guerri C; Guasch RM
J Neurochem; 2010 Feb; 112(4):1074-87. PubMed ID: 19968760
[TBL] [Abstract][Full Text] [Related]
9. RhoE controls myoblast alignment prior fusion through RhoA and ROCK.
Fortier M; Comunale F; Kucharczak J; Blangy A; Charrasse S; Gauthier-Rouvière C
Cell Death Differ; 2008 Aug; 15(8):1221-31. PubMed ID: 18369372
[TBL] [Abstract][Full Text] [Related]
10. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
11. RhoE function is regulated by ROCK I-mediated phosphorylation.
Riento K; Totty N; Villalonga P; Garg R; Guasch R; Ridley AJ
EMBO J; 2005 Mar; 24(6):1170-80. PubMed ID: 15775972
[TBL] [Abstract][Full Text] [Related]
12. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
13. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
[TBL] [Abstract][Full Text] [Related]
14. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.
Wong CC; Wong CM; Tung EK; Au SL; Lee JM; Poon RT; Man K; Ng IO
Gastroenterology; 2011 Jan; 140(1):322-31. PubMed ID: 20951699
[TBL] [Abstract][Full Text] [Related]
15. RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
Ma W; Sze KM; Chan LK; Lee JM; Wei LL; Wong CM; Lee TK; Wong CC; Ng IO
Oncotarget; 2016 Jul; 7(27):41445-41459. PubMed ID: 27213590
[TBL] [Abstract][Full Text] [Related]
16. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
17. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
19. RhoE is associated with relapse and prognosis of patients with colorectal cancer.
Zhou J; Yang J; Li K; Mo P; Feng B; Wang X; Nie Y; Fan D
Ann Surg Oncol; 2013 Jan; 20(1):175-82. PubMed ID: 22941156
[TBL] [Abstract][Full Text] [Related]
20. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.
Zhang X; Liu S; Hu T; Liu S; He Y; Sun S
Hepatology; 2009 Aug; 50(2):490-9. PubMed ID: 19472311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]